This resource is made possible through the NIST Biomanufacturing Program which develops measurement science, standards, reference data and tools to support the development, manufacturing, and regulatory approval of biologic medicines. The initial phase has been geared toward improving comprehensive analysis of monoclonal antibody therapeutics through the development of the NISTmAb Reference Material 8671 and numerous associated innovative technologies, round-robin studies, and open innovation collaborations. Industry feedback on the utility of such pre-competitive standards and associated knowledge space has spurred continued efforts to facilitate the development of additional widely available test metrics (e.g. cell lines and/or other modalities). This hub will serve as the center for future measurements science and reference materials to advance the development, manufacture and regulatory approval of biopharmaceuticals.